Drug Trial Radar · NCT06348290
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
Last checked: Nov 20, 2026Latest source record: Apr 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
72
Planned (sponsor's estimate)
Start
Apr 1, 2024
Primary completion
May 31, 2024
Study completion Sep 15, 2024
Sponsor
- Lead sponsor
- JemincareIndustry
- Sponsor type
- Industry
- First posted
- Apr 4, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is an open-label, non-randomized, clinical study to evaluate the drug interaction between itraconazole, rifampin or Cocktail and JMKX001899 in healthy subjects. A total of three cohorts of 72 healthy subjects were planned to be enrolled in each cohort.
Conditions
- Solid Tumor, Adult
Interventions
JMKX001899Drug
Oral
ItraconazoleDrug
Oral
MidazolamDrug
Oral
RifampinDrug
Oral
dextromethorphanDrug
Oral
RosuvastatinDrug
Oral
digoxinDrug
Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- maximum concentrations (Cmax ) for plasmaTime frame: approximately 3 days after first dose
- area under the curve from time 0 to infinity(AUC0-inf) for plasmaTime frame: approximately 3 days after first dose
- area under the curve from time 0 to the last time point (AUC0-t) for plasmaTime frame: approximately 3 days after first dose
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.